The prognostic impact of human epidermal growth factor receptor 2 (HER2) status in metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Starling, N. [1 ]
Snider, J. [2 ]
Cho-Phan, C. [2 ]
Wang, J. [2 ]
Martin, P. [3 ]
Simon, C. [3 ]
Bartley, K. [4 ]
机构：
[1] Royal Marsen NHS Fdn Trust, Gastrointestinal Unit, Surrey, England
[2] Flatiron Hlth, New York, NY USA
[3] Pfizer Inc, Med Affairs, Sandwich, Kent, England
[4] Pfizer Inc, Hlth Econ & Outcomes Res, San Francisco, CA USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
75P
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [41] Development of a monoclonal antibody against human epidermal growth factor receptor 2 (HER2)
    Takei, Junko
    Kaneko, Mika
    Ohishi, Tomokazu
    Sayama, Yusuke
    Kawada, Manabu
    Harada, Hiroyuki
    Kato, Yukinari
    CANCER SCIENCE, 2021, 112 : 545 - 545
  • [42] Human epidermal growth factor receptor 2 (HER2) expression in urothelial carcinomas of the bladder
    Nalwa, A.
    Elhence, A. B. S. P.
    Bharti, J. Naresh
    Rao, M.
    Choudhary, G. Ram
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S170 - S171
  • [43] Human epidermal growth factor receptor 2 (HER2/neu) supraexpression in the mammary tumors
    Moise, M.
    Motoc, A.
    Raducan, Andreea
    Raducan, S.
    Niculescu, V.
    Niculescu, M.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (03): : 1101 - 1105
  • [44] Prognostic and predictive significance of insulin-like growth factor-1 receptor (IGF-1R), epidermal growth factor receptor (EGFR), and HER2 in metastatic colorectal cancer.
    Yamada, Y
    Goto, A
    Ura, T
    Yasui, H
    Kato, K
    Hamaguchi, T
    Muro, K
    Shimada, Y
    Shimoda, T
    Shirao, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 873S - 873S
  • [45] Relationship between human epidermal growth factor receptor 2 (HER2) status and central nervous system metastases in gastroesophageal cancer.
    Ma, Lucy Xiaolu
    Lim, Charles Henry
    Sun, Peiran
    Jiang, Maria
    Sim, Hao-Wen
    Natori, Akina
    Chan, Bryan Anthony
    Yokom, Daniel
    Moignard, Stephanie
    Le, Lisa W.
    Chen, Eric Xueyu
    Liu, Geoffrey
    Swallow, Carol Jane
    Darling, Gail Elizabeth
    Kongkham, Paul N.
    Shultz, David
    Hafezi-Bakhtiari, Sara
    Conner, James
    Elimova, Elena
    Jang, Raymond Woo-Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [46] Quantitative parameters of magnetic resonance imaging cannot predict human epidermal growth factor receptor 2 (HER2) status in rectal cancer
    Huang, Zhenhuan
    Tu, Xuezhao
    Lin, Qi
    Zhan, Zejuan
    Li, Ying
    Liu, Jinkai
    CLINICAL IMAGING, 2022, 83 : 77 - 82
  • [47] Amplification of the human epidermal growth factor receptor 2 (HER2) gene is associated with a microsatellite stable status in Chinese gastric cancer patients
    Huang, He
    Wang, Zhengkun
    Li, Yi
    Zhao, Qun
    Niu, Zhaojian
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (02) : 377 - +
  • [48] Assessment of Estrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor Receptor 2 (HER2) Status in the Fine Needle Aspirates of Metastatic Breast Carcinomas
    Monaco, Sara E.
    Wu, Yue
    Teot, Lisa A.
    Cai, Guoping
    DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (04) : 308 - 315
  • [49] Prognostic influence of preoperative plasma levels of Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) on disease outcomes following radical cystectomy
    Oberneder, K.
    Klemm, J.
    Schuettfort, V
    Laukhtina, E.
    Shariat, S. F.
    EUROPEAN UROLOGY, 2024, 85 : S875 - S876
  • [50] HER2 amplification as a negative predictive biomarker for anti-epidermal growth factor receptor antibody therapy in metastatic colorectal cancer.
    Raghav, Kanwal Pratap Singh
    Overman, Michael J.
    Yu, Ruoxi
    Meric-Bernstam, Funda
    Menter, David
    Kee, Bryan K.
    Muranyi, Andrea
    Singh, Shalini
    Routbort, Mark
    Chen, Ken
    Shaw, Kenna Rael
    Shanmugam, Kandavel
    Maru, Dipen M.
    Fakih, Marwan
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345